Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing ...

though some experts were skeptical that the topline results were adequate to prove the benefits of the drug. In a Phase 2b trial, older patients taking Novo Nordisk’s Wegovy and Veru’s ...

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing weight. In ...

Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the drugs are approved for other chronic conditions ...

Ozempic and Wegovy are the most well-known drugs belonging ... This new study suggests there are a number of benefits from taking these drugs, but it doesn't directly say that the use of the ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

open image in gallery Experts say more research is needed to confirm any added benefits of GLP-1RA drugs, which include Ozempic and Wegovy (PA Wire) Using a median of three and a half years of ...